Search results
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 7 days agoIn Q1, FreeStyle Libre raked in $1.2 billion in sales -- over 12% of Abbott's total revenue....
Josh Groban Will Host the 15th Annual Jimmy Awards
Broadway World· 2 days agoThe Broadway League Foundation just announced that EMMY, two-time TONY, and five-time GRAMMY Award-nominated singer, songwriter, actor, and...
Leonard Schleifer
Fortune· 2 days agoToday its monoclonal antibodies, particularly Eylea for retinal diseases, are producing major cash injections for the company. Indeed, Eylea is on track for mega-blockbuster
Exclusive: Inside De Beers’ About-Face on Lab-Grown Diamonds
The Business of Fashion· 6 days agoIn 2018, De Beers, the 136-year-old diamond company, shocked the jewellery industry when it...
Price Chart for Leading Subscription Video Streaming Services: Updated With New Max Prices
Variety· 1 day agoThe week before the show’s first season premiere in 2022 (and amid the company’s Great Content...
Nvidia: Possible Under The Radar Risks
Investing.com via Yahoo Finance· 6 days agoData center revenue, which roughly translates to Nvidia's all-important artificial intelligence chips, spiked by 427% year-on-year to a record $22.6 billion...09 a share a ...
The Summer Box Office Crisis: Is the Sky Really Falling This Time?
The Hollywood Reporter· 13 hours agoWithin minutes of the actors strike ending on Nov. 9, Ryan Reynolds was making plans to get back to...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
Walmart and Chipotle Soared After Announcing Stock Splits. Will Nvidia Be Next?
The Motley Fool via AOL· 2 days agoThey're choosing to split their shares because they believe their stock prices will continue to...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 7 days agoPfizer Once-booming COVID-19 vaccine sales have plunged, dragging down Pfizer's (NYSE: PFE) overall revenue and earnings. The big drugmaker faces a...
